Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Fate Therapeutics (FATE) stock
Learn how to easily invest in Fate Therapeutics stock.
Fate Therapeutics, Inc is a biotechnology business based in the US. Fate Therapeutics shares (FATE) are listed on the NASDAQ and all prices are listed in US Dollars. Fate Therapeutics employs 314 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Fate Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – FATE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Fate Therapeutics stock price (NASDAQ: FATE)Use our graph to track the performance of FATE stocks over time.
Fate Therapeutics shares at a glance
|Latest market close||$76.60|
|52-week range||$29.37 - $121.16|
|50-day moving average||$83.86|
|200-day moving average||$87.75|
|Wall St. target price||$111.71|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.22|
Buy Fate Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Fate Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Fate Therapeutics price performance over time
|1 week (2021-07-14)||N/A|
|1 month (2021-06-25)||-9.40%|
|3 months (2021-04-21)||N/A|
|6 months (2021-01-21)||N/A|
|1 year (2020-07-21)||N/A|
|2 years (2019-07-21)||N/A|
|3 years (2018-07-21)||N/A|
|5 years (2016-07-21)||N/A|
Fate Therapeutics financials
|Revenue TTM||$40.1 million|
|Gross profit TTM||$-94,189,000|
|Return on assets TTM||-12.78%|
|Return on equity TTM||-36.65%|
|Market capitalisation||$8.1 billion|
TTM: trailing 12 months
Shorting Fate Therapeutics shares
There are currently 11.8 million Fate Therapeutics shares held short by investors – that's known as Fate Therapeutics's "short interest". This figure is 0.5% up from 11.8 million last month.
There are a few different ways that this level of interest in shorting Fate Therapeutics shares can be evaluated.
Fate Therapeutics's "short interest ratio" (SIR)
Fate Therapeutics's "short interest ratio" (SIR) is the quantity of Fate Therapeutics shares currently shorted divided by the average quantity of Fate Therapeutics shares traded daily (recently around 1.1 million). Fate Therapeutics's SIR currently stands at 10.73. In other words for every 100,000 Fate Therapeutics shares traded daily on the market, roughly 10730 shares are currently held short.
However Fate Therapeutics's short interest can also be evaluated against the total number of Fate Therapeutics shares, or, against the total number of tradable Fate Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Fate Therapeutics's short interest could be expressed as 0.13% of the outstanding shares (for every 100,000 Fate Therapeutics shares in existence, roughly 130 shares are currently held short) or 0.1482% of the tradable shares (for every 100,000 tradable Fate Therapeutics shares, roughly 148 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Fate Therapeutics.
Find out more about how you can short Fate Therapeutics stock.
Fate Therapeutics share dividends
We're not expecting Fate Therapeutics to pay a dividend over the next 12 months.
Fate Therapeutics share price volatility
Over the last 12 months, Fate Therapeutics's shares have ranged in value from as little as $29.37 up to $121.16. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fate Therapeutics's is 1.6621. This would suggest that Fate Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Fate Therapeutics overview
Fate Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors, as well as ProTmune for the treatment of hematologic malignancies and rare genetic disorders. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of two off-the-shelf iPSC-derived CAR T-cell product candidates; strategic research collaboration and license agreement with Juno Therapeutics, Inc. to screen for and identify small molecule modulators that enhance the therapeutic properties of genetically-engineered T-cell immunotherapies; and a collaboration and option agreement with Janssen Biotech, Inc.
Stocks similar to Fate Therapeutics
Fate Therapeutics in the news
Did You See What Cathie Wood Bought on Wednesday?
Dowling & Yahnke Llc Buys Vanguard S&P 500 ETF, Fate Therapeutics Inc, MicroStrategy Inc, Sells , New Mountain Finance Corp, Sixth Street Specialty Lending Inc
IDNA And Healthcare Dashboard For July
Frequently asked questionsWhat percentage of Fate Therapeutics is owned by insiders or institutions?
Currently 1.77% of Fate Therapeutics shares are held by insiders and 102.288% by institutions. How many people work for Fate Therapeutics?
Latest data suggests 314 work at Fate Therapeutics. When does the fiscal year end for Fate Therapeutics?
Fate Therapeutics's fiscal year ends in December. Where is Fate Therapeutics based?
Fate Therapeutics's address is: 3535 General Atomics Court, San Diego, CA, United States, 92121 What is Fate Therapeutics's ISIN number?
Fate Therapeutics's international securities identification number is: US31189P1021 What is Fate Therapeutics's CUSIP number?
Fate Therapeutics's Committee on Uniform Securities Identification Procedures number is: 31189P102
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert